BRIEF

on RHÖN-KLINIKUM AG (ETR:RHK)

RHÖN-KLINIKUM AG Revises 2025 EBITDA Forecast Downward

Stock price chart of RHÖN-KLINIKUM AG (EBR:RHK) showing fluctuations.

RHÖN-KLINIKUM Aktiengesellschaft has revised its EBITDA forecast for 2025. The healthcare provider now anticipates an EBITDA between EUR 100 million and EUR 105 million. This is a shift from the earlier estimate of EUR 110 million to EUR 125 million. The adjustment comes amid unexpected business developments. These include delays in addressing increased personnel and material costs, alongside the impact of refinancing related costs and agreements with health insurers on legacy cases.

The company's management maintains the forecast for other key metrics from the previous financial year. RHÖN-KLINIKUM continues its strategic initiatives, such as digital transformation and partnerships to enhance healthcare delivery. The annual report for the financial year 2025 will be released on 26 March 2026.

R. E.

Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all RHÖN-KLINIKUM AG news